FDA Orange Book
Generic for Questran Light
Questran Light contains cholestyramine. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Questran Light is cholestyramine. 11 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
Run it in Rivvi
Map Questran Light and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Questran Light products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| powder, oral | EQ 4GM RESIN/PACKET | Discontinued | None | 16 | AB |
| powder, oral | EQ 4GM RESIN/SCOOPFUL | Discontinued | None | 16 | AB |
NDA 019669, held by BRISTOL MYERS CO. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic cholestyramine
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| AIPING PHARMACEUTICAL INC | 073263 | AB (A-rated, therapeutically equivalent) | February 22, 1996 | EQ 4GM RESIN/PACKET, EQ 4GM RESIN/SCOOPFUL |
| EPIC PHARMA LLC | 074557 | AB (A-rated, therapeutically equivalent) | August 15, 1996 | EQ 4GM RESIN/PACKET, EQ 4GM RESIN/SCOOPFUL |
| EPIC PHARMA LLC | 074558 | AB (A-rated, therapeutically equivalent) | August 15, 1996 | EQ 4GM RESIN/PACKET, EQ 4GM RESIN/SCOOPFUL |
| CHARTWELL RX SCIENCES LLC | 074561 | AB (A-rated, therapeutically equivalent) | August 15, 1996 | EQ 4GM RESIN/PACKET, EQ 4GM RESIN/SCOOPFUL |
| CHARTWELL RX SCIENCES LLC | 074562 | AB (A-rated, therapeutically equivalent) | August 15, 1996 | EQ 4GM RESIN/PACKET, EQ 4GM RESIN/SCOOPFUL |
| PH HEALTH LTD | 077204 | AB (A-rated, therapeutically equivalent) | August 26, 2005 | EQ 4GM RESIN/PACKET, EQ 4GM RESIN/SCOOPFUL |
| PH HEALTH LTD | 077203 | AB (A-rated, therapeutically equivalent) | August 26, 2005 | EQ 4GM RESIN/PACKET, EQ 4GM RESIN/SCOOPFUL |
| ZYDUS PHARMACEUTICALS USA INC | 202902 | AB (A-rated, therapeutically equivalent) | April 25, 2017 | EQ 4GM RESIN/PACKET, EQ 4GM RESIN/SCOOPFUL |
| ZYDUS PHARMACEUTICALS USA INC | 202901 | AB (A-rated, therapeutically equivalent) | July 2, 2018 | EQ 4GM RESIN/SCOOPFUL |
| AJANTA PHARMA LTD | 211119 | AB (A-rated, therapeutically equivalent) | April 6, 2020 | EQ 4GM RESIN/PACKET, EQ 4GM RESIN/SCOOPFUL |
| PHARMOBEDIENT CONSULTING | 209599 | AB (A-rated, therapeutically equivalent) | November 12, 2020 | EQ 4GM RESIN/PACKET, EQ 4GM RESIN/SCOOPFUL |
| PHARMOBEDIENT CONSULTING LLC | 209597 | AB (A-rated, therapeutically equivalent) | March 9, 2021 | EQ 4GM RESIN/PACKET, EQ 4GM RESIN/SCOOPFUL |
| ALKEM LABORATORIES LTD | 211856 | AB (A-rated, therapeutically equivalent) | October 19, 2021 | EQ 4GM RESIN/PACKET, EQ 4GM RESIN/SCOOPFUL |
| ALKEM LABORATORIES LTD | 211799 | AB (A-rated, therapeutically equivalent) | October 19, 2021 | EQ 4GM RESIN/PACKET, EQ 4GM RESIN/SCOOPFUL |
| AIPING PHARMACEUTICAL INC | 214877 | AB (A-rated, therapeutically equivalent) | January 21, 2022 | EQ 4GM RESIN/PACKET, EQ 4GM RESIN/SCOOPFUL |
| MACLEODS PHARMACEUTICALS LTD | 207294 | AB (A-rated, therapeutically equivalent) | November 21, 2024 | EQ 4GM RESIN/PACKET, EQ 4GM RESIN/SCOOPFUL |
| MICRO LABS LTD | 219318 | AB (A-rated, therapeutically equivalent) | March 5, 2026 | EQ 4GM RESIN/PACKET |
Questions
Is there a generic for Questran Light?
Yes. The generic name for Questran Light is cholestyramine. 11 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
What is the generic name for Questran Light?
The active ingredient in Questran Light is cholestyramine, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.